Sch 29482：对耐β-内酰胺类抗生素的肠杆菌科细菌和分枝杆菌的比较活性。 - Suppr | 超能文献

Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.

作者信息

Sanders C C, Sanders W E

出版信息

J Antimicrob Chemother. 1982 Feb;9 Suppl C:59-69. doi: 10.1093/jac/9.suppl_c.59.

DOI:10.1093/jac/9.suppl_c.59

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.Sch 29482：对耐β-内酰胺类抗生素的肠杆菌科细菌和分枝杆菌的比较活性。

J Antimicrob Chemother. 1982 Feb;9 Suppl C:59-69. doi: 10.1093/jac/9.suppl_c.59.

2

Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.β-内酰胺酶抑制剂CP-45,899与β-内酰胺类抗生素联合对多重耐药肠杆菌科细菌和假单胞菌属细菌的协同作用不一致。

Antimicrob Agents Chemother. 1981 Feb;19(2):361-3. doi: 10.1128/AAC.19.2.361.

3

Sch 29482: activity against susceptible and beta-lactam resistant variants of Enterobacteriaceae.Sch 29482：对肠杆菌科的敏感菌株及β-内酰胺耐药菌株的活性。

J Antimicrob Chemother. 1982 Feb;9 Suppl C:203-12. doi: 10.1093/jac/9.suppl_c.203.

4

Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.使用β-内酰胺/β-内酰胺酶抑制剂治疗产超广谱β-内酰胺酶肠杆菌科细菌所致感染，以减缓耐碳青霉烯类肠杆菌科细菌的出现。

Expert Rev Anti Infect Ther. 2017 Oct;15(10):893-895. doi: 10.1080/14787210.2017.1380519. Epub 2017 Sep 21.

5

In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.Sch 34343的体外评估：抗菌活性、β-内酰胺酶稳定性及抑制作用

J Antimicrob Chemother. 1985 Jun;15 Suppl C:99-109. doi: 10.1093/jac/15.suppl_c.99.

6

beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae.

J Antimicrob Chemother. 1985 Jun;15 Suppl C:111-7. doi: 10.1093/jac/15.suppl_c.111.

7

Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.Sch 34343对链球菌和耐β-内酰胺类肠杆菌科细菌的活性。

J Antimicrob Chemother. 1985 Jun;15 Suppl C:147-54. doi: 10.1093/jac/15.suppl_c.147.

8

Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae.肠杆菌科临床分离株中β-内酰胺酶产生与对β-内酰胺类抗生素耐药性的关系。

Microbiologica. 1984 Jul;7(3):209-18.

9

In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.新型青霉烯抗生素Sch 34343的体外活性、β-内酰胺酶稳定性及抑制特性

J Antimicrob Chemother. 1985 Jun;15 Suppl C:25-37. doi: 10.1093/jac/15.suppl_c.25.

10

Indication of Minimum Inhibitory Concentration of β-Lactam Antimicrobials for the Primary Extraction of IMP-Producing Enterobacteriaceae.β-内酰胺类抗菌药物对产IMP肠杆菌科细菌初次分离的最低抑菌浓度指征

Jpn J Infect Dis. 2019 Jan 23;72(1):68-70. doi: 10.7883/yoken.JJID.2018.297. Epub 2018 Oct 31.

引用本文的文献

1

Characterization of beta-lactamase induction in Enterobacter cloacae.阴沟肠杆菌中β-内酰胺酶诱导的特征分析。

Antimicrob Agents Chemother. 1983 Jan;23(1):91-7. doi: 10.1128/AAC.23.1.91.

2

Selection of resistant mutants of Citrobacter freundii by second and third-generation cephalosporins and imipenem.用第二代和第三代头孢菌素以及亚胺培南筛选弗氏柠檬酸杆菌的耐药突变体。

Infection. 1984 Nov-Dec;12(6):402-4. doi: 10.1007/BF01645225.

3

Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。

Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.